Introcerebroventricular injection of AgRP or its expression in a transgenic mouse model both lead to hyperphagia, lowered energy expenditure, and obesity (Graham et al., 1997; Rossi et al., 1998; Small et al., 2001). The gene discussed is AGRP; the disease is obesity due to melanocortin 4 receptor deficiency.